| X | ||||||||||
- Definition Amount of general and administrative expense classified as personnel-related costs. These are the costs associated with the people and involved in general and administrative activities. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development attributable to Discovery-stage programs. This refers to the early stages of research and development where new drug candidates or therapies are being discovered and initially tested. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development attributable to Personnel-related and other internal costs. These are the costs associated with the people and internal resources involved in Research and Development activities. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development for products containing specified ingredient. Excludes personnel-related and other internal costs. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development for products with specified ingredient classified as other. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Description of composition of other segment item not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|